Recent News for MRSN - Mersana Therapeutics, Inc.

Date Title
May 23 Mersana Therapeutics: ADC Specialist Pursuing A Novel Target
May 20 Mersana Therapeutics to Present Interim Phase 1 Data on XMT-1536 at the 2019 American Society of Clinical Oncology Annual Meeting
May 17 63 Biggest Movers From Yesterday
May 17 Mersana Therapeutics, Inc. (MRSN) Q1 2019 Earnings Call Transcript
May 12 Mersana Therapeutics, Inc. (MRSN) CEO Anna Protopapas on Q1 2019 Results - Earnings Call Transcript
May 9 Mersana Therapeutics EPS of $0.70
May 9 Mersana Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Updates
May 2 Mersana Therapeutics to Host Conference Call Announcing First Quarter 2019 Financial Results and Business Updates
Apr 29 Consider These 3 Falling Knives
Apr 9 Mersana Therapeutics (MRSN) Presents At H.C. Wainwright & Co. Annual Global Life Sciences Conference - Slideshow
Apr 9 New Research: Key Drivers of Growth for Liberty Global, KKR Real Estate Finance Trust, AGCO, Model N, STAAR Surgical, and Mersana Therapeutics — Factors of Influence, Major Initiatives and Sustained Production
Apr 1 Mersana Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 25 Mersana Therapeutics Announces Poster and Presentation at the American Association for Cancer Research Annual Meeting 2019
Mar 12 What Should You Know About Mersana Therapeutics, Inc.’s (NASDAQ:MRSN) Earnings Trajectory?
Mar 11 JPMorgan Downgrades Mersana, Says Data Readouts Unlikely To Reverse Street Sentiment
Mar 9 Mersana Therapeutics (MRSN) CEO Anna Protopapas on Q4 2018 Results - Earnings Call Transcript
Mar 8 The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings
Mar 8 Mersana Therapeutics Q4 top line down 64%
Mar 8 Mersana Therapeutics misses by $0.25, misses on revenue
Mar 8  Mersana Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Business Updates
Mar 8 Earnings Scheduled For March 8, 2019
Mar 6 Mersana Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference
Mar 5 Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 4 81 Biggest Movers From Friday
Mar 1 Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2018 Financial Results and Business Updates

Back to the Main MRSN Page...